T/CACM 1169-2019 Active Group standards

T/CACM 1169-2019 Chinese Internal Medicine: Guideline for the Clinical Management of Asthma (Chronic Obstructive Pulmonary Disease with Right Heart Failure)

Publish Date: 2019-01-30 Implement Date: 2020-01-01 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Price: $ 20.00

Out of stock

Basic Information

Standard Code: T/CACM 1169-2019

Standard Type: Group standards

Standard Status: Active

is_force_gb: no

CCS Name: Medicine

ICS Name: Comprehensive Pharmaceutical Science

Publish Date: 2019-01-30

Implement Date: 2020-01-01

Scope

Main technical content: This guideline mainly provides diagnosis, differentiation and treatment recommendations based on traditional Chinese medicine for asthma (chronic obstructive pulmonary disease with right heart failure). The treatment drugs and methods recommended in this guideline are suitable for adults over the age of 18. Children, pregnant and postpartum women, and patients with severe organ dysfunction need to be further carefully evaluated when applying this guideline for treatment. This guideline is suitable for clinicians such as doctors of traditional Chinese medicine, respiratory doctors, emergency doctors, and community doctors for reference and use. The traditional Chinese medicines, proprietary Chinese medicines, or other traditional Chinese medicine therapies mainly recommended in this guideline cannot completely replace modern medical treatment methods.